The global cell lysis market size is projected to reach USD 4.1 billion by 2026 from USD 2.9 billion in 2021, at a CAGR of 7.2% during the forecast period. Growth of the market is driven mainly by increasing government funding for research, high prevalence of diseases and growing focus on personalized medicine.
Covid -19 Impact On The Cell Lysis Market
Due to the rapid spread of the coronavirus, the demand for diagnostic kits and other critical care medical devices has witnessed exponential growth in the last two quarters. Currently, healthcare provider facilities across the globe are overwhelmed with patient submissions for COVID-19 screening & treatment. This has resulted in severe disruptions in clinical workflows within inpatient care facilities, leading to prioritizing critical patient care procedures by provider facilities. However, government and corporate investments have increased significantly to drive the manufacturing and supply of medical supplies required to cater to infected patients. This has pressured stakeholders to strengthen their existing manufacturing capabilities and supply chains. The life sciences industry and multinational organizations & smaller companies are working round-the-clock to meet this demand and make tests available.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=260138321
Consumables accounted for the larger share of the cell lysis market in 2020
Based on the product, the cell lysis market is segmented into consumables and instruments. In 2020, the consumables segment accounted for the larger share of the cell lysis market. The large share of this segment can be attributed to repeated purchase and high consumption, the high prevalence of diseases, and increasing funding for cell-based research.
By cell type, the mammalian cells segment accounted for the largest market share in 2020
Based on the cell type, the cell lysis market is segmented into mammalian cell, microbial cell and other cell. The mammalian cell segment accounted for the largest market share in 2020. The increasing investments in research activities to develop new disease treatments and industrial applications are major driving factors for this market.
Research laboratories and institutes are the largest end-users of the cell lysis market
Based on end-users, the cell lysis market is segmented into research laboratories & institutes, biopharmaceutical & biotechnology companies, and other end users. The research laboratories & institutes segment accounted for the largest market share in 2020 due to the increasing number of rising government funding for cell-based research.
North America dominates the global cell lysis market
The cell lysis market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World. In 2018, North America accounted for the largest share of the cell lysis market. The large share of North America can be attributed to factors such as the Growing stem cell and cancer research activities and the expanding biotechnology & pharmaceutical industries
The major players in the cell lysis market are Thermo Fisher Scientific (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), Danaher Corporation (US), Bio-Rad Laboratories (US), Cell Signaling Technology Inc. (US), Miltenyi Biotec (Germany), Roche Diagnostics (Switzerland), and QIAGEN N.V. (Netherlands).